TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
5,437
|
4,828
|
5,580 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
575
|
654
|
996 |
| EBITDA |
577
|
676
|
1,021 |
| Total assets |
1,400
|
1,803
|
2,267 |
| Current assets |
1,247
|
1,739
|
2,209 |
| Current liabilities |
937
|
1,365
|
1,791 |
| Equity capital |
463
|
438
|
476 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
14
|
13
|
12 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
33.1%
|
24.3%
|
21.0% |
| Turnover per employee |
388
|
371
|
465 |
| Profit as a percentage of turnover |
10.6%
|
13.5%
|
17.8% |
| Return on assets (ROA) |
41.1%
|
36.3%
|
43.9% |
| Current ratio |
133.1%
|
127.4%
|
123.3% |
| Return on equity (ROE) |
124.2%
|
149.3%
|
209.2% |
| Change turnover |
595
|
-300
|
252 |
| Change turnover % |
12%
|
-6%
|
5% |
| Chg. No. of employees |
1
|
1
|
2 |
| Chg. No. of employees % |
8%
|
8%
|
20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.